Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 221

Results For "EMA"

2287 News Found

Vikas Lifecare acquires 22.04% stake in Advik Laboratories
News | July 15, 2021

Vikas Lifecare acquires 22.04% stake in Advik Laboratories

Vikas Lifecare has already paid Rs. 25 million to the Advik bankers till date and the remaining amount shall also be paid within July 2021, making Advik a debt free company


Brooks announces new investments to build an integrated carbapenem business
News | July 15, 2021

Brooks announces new investments to build an integrated carbapenem business

SteriScience will infuse an additional amount of Rs. 74.5 crore, making a total investment commitment of Rs. 114.5 crore in BSL


Pfizer and BioNTech expects third dose clinical studies of COVID-19 vaccine in August
News | July 09, 2021

Pfizer and BioNTech expects third dose clinical studies of COVID-19 vaccine in August

The companies anticipate clinical studies to begin in August, subject to regulatory approvals


Ajooni Biotech to establish first Oxygen Park in Punjab
News | July 05, 2021

Ajooni Biotech to establish first Oxygen Park in Punjab

Oxygen Park is a concept where a two-layer layout is being used to plant oxygen releasing trees which releases oxygen for 24 hours


Cipla receives final approval for generic version of Brovana
News | June 24, 2021

Cipla receives final approval for generic version of Brovana

Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana


Vaishali Pharma bags $100,000 order from Russia
News | June 23, 2021

Vaishali Pharma bags $100,000 order from Russia

The company has predominantly built a portfolio into veterinary products


Jubilant HollisterStier to manufacture COVID-19 Vaccine COVAXIN in US
News | June 15, 2021

Jubilant HollisterStier to manufacture COVID-19 Vaccine COVAXIN in US

Entered into a manufacturing partnership with Ocugen, Inc. for manufacturing of COVID-19 vaccine COVAXIN for the US and Canadian markets


Sun Pharma’s US Specialty business to grow at 21% CAGR in 2 years
News | June 14, 2021

Sun Pharma’s US Specialty business to grow at 21% CAGR in 2 years

The company expects to see steady performance led by new launches and gradual normalization post the scale-up in vaccination


'We plan to invest Rs. 1,000 Cr in the next 3 to 4 years.' Priyanka Chigurupati, Executive Director, Granules Pharmaceutical Inc.
Interviews | June 10, 2021

'We plan to invest Rs. 1,000 Cr in the next 3 to 4 years.' Priyanka Chigurupati, Executive Director, Granules Pharmaceutical Inc.

In an exclusive interview with Rahul Koul of Indian Chemical News, Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals Inc. USA shared details about the company's performance, R&D initiatives, Capex plan, CSR, and future outlook. Excerpts of the interview:


Trials of three more vaccines are in advanced stage: Modi
News | June 08, 2021

Trials of three more vaccines are in advanced stage: Modi

The Prime Minister announced that 21st June onwards, the Government of India will provide free vaccines to all Indian citizens above 18 years of age